One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Table of Contents
doi : 10.1016/S1526-5900(23)00004-4
Volume 24, Issue 2, February 2023, Pages A4-A6
Promoting Inclusion, Diversity, and Equity in Pain Science
Tonya M. PalermoKaren Deborah DavisDidier BouhassiraRobert W. HurleyJoel D. KatzFrancis J. KeefeMichael SchatmanDennis C. TurkDavid Yarnitsky
doi : 10.1016/j.jpain.2022.11.005
Volume 24, Issue 2, February 2023, Pages 187-191
Systematic Review and Meta-Analysis of the Prevalence of Chronic Pain Among Patients With Opioid Use Disorder and Receiving Opioid Substitution Therapy
Jessica Delorme,*,y Nicolas Kerckhove,* ,y,z Nicolas Authier,*,y,z Bruno Pereira,x Celian Bertin,*,y,z and Chouki Chenaf
doi : 10.1016/j.jpain.2022.08.008
Volume 24, Issue 2, February 2023, Pages 192-203
To assess studies examining the prevalence of chronic pain (CP) in patients treated with Opioid Substitution Treatment (OST - buprenorphine or methadone) for Opioid Used Disorder (OUD), we conducted a systematic review and meta-analysis of the literature between the years 2000 and 2020. We searched EMBASE, PsycINFO, Cochrane, and MEDLINE databases and included studies assessing the prevalence of CP in OUD adults treated with OST.
Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations
Robert R. Edwards,* Kristin L. Schreiber,* Robert H. Dworkin,y Dennis C. Turk,z Ralf Baron,x Roy Freeman,* Troels S. Jensen,{ Alban Latremoliere,k John D. Markman,y Andrew S.C. Rice,** Michael Rowbotham,yy Roland Staud,zz Simon Tate,xx Clifford J. Woolf,* Nick A. Andrews,{{ Daniel B. Carr,kk Luana Colloca,*** Doina Cosma-Roman,yyy Penney Cowan,zzz Luda Diatchenko,xxx John Farrar,{{{ Jennifer S. Gewandter,y Ian Gilron,**** Robert D. Kerns,yyyy Serge Marchand,zzzz Gwendolyn Niebler,xxxx Kushang V. Patel,z Lee S. Simon,{{{{ Tina Tockarshewsky,
doi : 10.1016/j.jpain.2022.08.010
Volume 24, Issue 2, February 2023, Pages 204-225
Large variability in the individual response to even the most-efficacious pain treatments is observed clinically, which has led to calls for a more personalized, tailored approach to treating patients with pain (ie, “precision pain medicine�).
Multifocal tDCS Targeting the Motor Network Modulates Event-Related Cortical Responses During Prolonged Pain
Luisina Gregoret,*,y Anna M. Zamorano,* and Thomas Graven-Nielsen
doi : 10.1016/j.jpain.2022.09.010
Volume 24, Issue 2, February 2023, Pages 226-236
Multifocal transcranial direct current stimulation (tDCS) targeting several brain regions is promising for inducing cortical plasticity.
A New Instrument for Assessing Work-Related Body Mechanics and Strain in the General Population
Sonia Sharma,* ,y Peter M. Nilsson,z,x Per-Olof €Ostergren,x,{ Birgitta H€aggman-Henrikson, y,k Thomas List,y, ** and Michael A. Kallen
doi : 10.1016/j.jpain.2022.09.011
Volume 24, Issue 2, February 2023, Pages 237-250
Clinical pain is often linked to poor body mechanics, with individuals sometimes presenting multiple painful disorders. Such disorders may be influenced by behaviors that affect the general resiliency and health of the musculoskeletal system.
Education-Enhanced Conventional Care versus Conventional Care Alone for Temporomandibular Disorders: A Randomized Controlled Trial
Aroldo d.S. Aguiar,* G. Lorimer Moseley,y Cesar Bataglion,z Beatriz Azevedo, & and Thaıs C. Chaves
doi : 10.1016/j.jpain.2022.09.012
Volume 24, Issue 2, February 2023, Pages 251-263
The objective of this study was to determine the effect of enhancing conventional care for people with chronic painful temporomandibular disorders (TMD) with an individualised contemporary pain science education (PSE) intervention.
The Delta-Opioid Receptor Bidirectionally Modulates Itch
Kelly M. Smith,�,y,2 Eileen Nguyen,�,y,z,2 and Sarah E. Ross
doi : 10.1016/j.jpain.2022.09.013
Volume 24, Issue 2, February 2023, Pages 264-272
Opioid signaling has been shown to be critically important in the neuromodulation of sensory circuits in the superficial spinal cord. Agonists of the mu-opioid receptor (MOR) elicit itch, whereas agonists of the kappa-opioid receptor (KOR) have been shown to inhibit itch.
Mental Health Diagnoses are Not Associated With Indicators of Lower Quality Pain Care in Electronic Health Records of a National Sample of Veterans Treated in Veterans Health Administration Primary Care Settings
Steven K. Dobscha,y,z Stephen L. Luther,x,{ Robert D. Kerns,k, ** Dezon K. Finch,x Joseph L. Goulet,k,yy Cynthia A. Brandt,k,yy Melissa Skanderson,k Harini Bathulapalli,k Samah J. Fodeh,k,yy Bridget Hahm,x Lina Bouayad,x,zz Allison Lee,k, ** and Ling Han
doi : 10.1016/j.jpain.2022.08.009
Volume 24, Issue 2, February 2023, Pages 273-281
Prior research has demonstrated disparities in general medical care for patients with mental health conditions, but little is known about disparities in pain care.
Moderators and Nonspecific Predictors of Treatment Benefits in a Randomized Trial of Mindfulness-Based Stress Reduction vs Cognitive-Behavioral Therapy vs Usual Care for Chronic Low Back Pain
Jessica A. Chen,*,y,# Melissa L. Anderson,z Daniel C. Cherkin,z Benjamin H. Balderson,z Andrea J. Cook,z Karen J. Sherman,z and Judith A. Turner
doi : 10.1016/j.jpain.2022.09.014
Volume 24, Issue 2, February 2023, Pages 282-303
Both mindfulness-based stress reduction (MBSR) and cognitive-behavioral therapy (CBT) are effective for chronic low back pain (CLBP), but little is known regarding who might benefit more from one than the other. Using data from a randomized trial comparing MBSR, CBT, and usual care (UC) for adults aged 20 to 70 years with CLBP (N = 297), we examined baseline characteristics that moderated treatment effects or were associated with improvement regardless of treatment.
Minocycline Prevents the Development of Key Features of Inflammation and Pain in DSS-induced Colitis in Mice
Teresa Vezza,*,& Jose Alberto Molina-Tijeras,*,y,& Rafael Gonzalez-Cano,*,y,z Alba Rodrıguez-Nogales,*,y Federico Garcıa,y,x Julio Galvez,*,y,{,# and Enrique J. Cobos
doi : 10.1016/j.jpain.2022.09.016
Volume 24, Issue 2, February 2023, Pages 304-319
Abdominal pain is a common feature in inflammatory bowel disease (IBD) patients, and greatly compromises their quality of life. Therefore, the identification of new therapeutic tools to reduce visceral pain is one of the main goals for IBD therapy.
Association of Common Pediatric Surgeries With New Onset Chronic Pain in Patients 0-21 Years of Age in the United States
Isha Thapa,* Elizabeth De Souza,y Andrew Ward,z Nicholas Bambos,x and Thomas Anthony Anderson
doi : 10.1016/j.jpain.2022.09.015
Volume 24, Issue 2, February 2023, Pages 320-331
Chronic pain (CP) is a major public health issue. While new onset CP is known to occur frequently after some pediatric surgeries, its incidence after the most common pediatric surgeries is unknown.
Improving Power and Accuracy in Randomized Controlled Trials of Pain Treatments by Accounting for Concurrent Analgesic Use
Pradeep Suri,*,y,z,x Patrick J. Heagerty,{ Anna Korpak,* Mark P. Jensen,x Laura S. Gold,z,k Kwun C.G. Chan,{ Andrew Timmons,* Janna Friedly,z,x Jeffrey G. Jarvik,z,k and Aaron Baraff
doi : 10.1016/j.jpain.2022.09.017
Volume 24, Issue 2, February 2023, Pages 332-344
The 0 to 10 numeric rating scale of pain intensity is a standard outcome in randomized controlled trials (RCTs) of pain treatments.
Benzodiazepine Use and Dependence in Relation to Chronic Pain Intensity and Pain Catastrophizing
Emma C. Lape,* Jessica M. Powers,* Julia E. Hooker,* Robert R. Edwards,y and Joseph W. Ditre
doi : 10.1016/j.jpain.2022.09.019
Volume 24, Issue 2, February 2023, Pages 345-355
Benzodiazepines (BZDs), a class of sedative-hypnotic medications, generated concern as their popularity grew, with particular alarm regarding elevated rates of BZD use among chronic pain populations.
Patient Responses to the Term Pain Catastrophizing: Thematic Analysis of Cross-sectional International Data
Fiona Webster,* Laura Connoy,* Riana Longo,* Devdeep Ahuja,y Dagmar Amtmann,z Andrea Anderson,x Claire E. Ashton-James,{ Hannah Boyd,║ Christine T. Chambers,** Karon F. Cook,yy Penney Cowan,zz Geert Crombez,xx Amanda B. Feinstein,{{ Anne Fuqua,║║ Gadi Gilam,*** Isabel Jordan,yyy Sean C. Mackey,zzz Eduarda Martins,xxx Lynn M. Martire,{{{ Peter O’Sullivan,║║║ Dawn P. Richards,**** Judith A. Turner,yyyy Christin Veasley,zzzz Hanne W€urtzen,xxxx Su-Yin Yang,{{{{ Dokyoung S. You,zzz Maisa Ziadni,zzz and Beth D. Darnallzzz
doi : 10.1016/j.jpain.2022.10.001
Volume 24, Issue 2, February 2023, Pages 356-367
Pain catastrophizing is understood as a negative cognitive and emotional response to pain. Researchers, advocates and patients have reported stigmatizing effects of the term in clinical settings and the media.
